Showing 1 - 10 of 1,085
Governments in many low- and middle-income countries are developing health insurance products as a complement to tax-funded, subsidized provision of health care through publicly operated facilities. This paper discusses two rationales for this transition. First, health insurance would boost...
Persistent link: https://www.econbiz.de/10014247916
Persistent link: https://www.econbiz.de/10001511637
The United States is in the midst of a revolution in health care finance, the third since the end of World War II. Medicare's prospective payment system (PPS) based on diagnosis-related groups (DRGs), the State of California's hospital-specific contracts for Medi-Cal patients, deductibles and...
Persistent link: https://www.econbiz.de/10012477477
This paper examines one of the possible factors which has contributed to the significant recent growth in the Social Security Administration's Disability Insurance program: that of health care incentives under the program. The examination of health care incentives involves a 2-period, 2-state...
Persistent link: https://www.econbiz.de/10012478298
U.S. physicians are increasingly joining multispecialty group practices. In this paper, we analyze how a primary care physician's practice type - single (SSP) versus multispecialty practice (MSP) - affects health care spending and use. Focusing on Medicare beneficiaries who change their primary...
Persistent link: https://www.econbiz.de/10012479865
A literature has found that medical providers inflate bills and report more conditions given financial incentives. We evaluate whether Medicare reimbursement incentives are driven more by bill inflation or coding costs. Medicare reformed its payment mechanism for inpatient hospitalizations in...
Persistent link: https://www.econbiz.de/10012480398
We evaluate the effect of tort reform on employer-sponsored health insurance premiums by exploiting state-level variation in the timing of reforms. Using a dataset of healthplans representing over 10 million Americans annually between 1998 and 2006, we find that caps on non-economic damages,...
Persistent link: https://www.econbiz.de/10012463279
A controversial feature of Medicare Part D is its reliance on private insurers to negotiate drug prices and rebates with retail pharmacies and drug manufacturers. Central to this controversy is whether increases in market power--an undesirable feature in most settings--confer benefits in health...
Persistent link: https://www.econbiz.de/10012463320
We use unique data from an insurer that exclusively offers high-deductible, "consumer-directed" health plans to identify the effect of plan features, notably the spending account, on health care spending. Our results show that the marginal dollar in the spending account is entirely spent on...
Persistent link: https://www.econbiz.de/10012463544
This paper examines the economic rationale of affordability exemptions in the context of a health insurance mandate. On its face, an affordability exemption makes little sense-- it exempts people from purchasing a good that policymakers believe benefits them. I provide an economic definition of...
Persistent link: https://www.econbiz.de/10012464102